Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis
Liver International · 2026
DOI: 10.1111/liv.70802 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Liver International, 2026. Verfasst von Christian Hobeika und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of HPB Surgery and Liver Transplantation, Beaujon Hospital, AP-HP, Clichy, Paris-Cité University, Paris, France. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Liver Cirrhosis, Hepatectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background & Aims We compared multibipolar radiofrequency ablation (mbpRFA) with open liver resection (OLR) or laparoscopic liver resection (LLR) in patients with HCCs within Milan.
Methods
This multicenter cohort study included patients treated by mbpRFA, OLR or LLR for HCC within the Milan Criteria, developed on advanced fibrosis in nine French centres between 2008 and 2018. Adjustments on HCC size/number, gender, age, ASA, HCV, HBV, metabolic syndrome, chronic alcohol intake, MELD score, serum AFP level, APRI score, cirrhosis, significant portal hypertension and HCC localization were performed using multivariable regressions with centre‐robust variance and propensity score‐based matching (3:1 nearest‐neighbour with calliper < 0.1; effective ratios 2.18:1 and 2.43:1).
Results
1040 patients were included (median age: 64 years; male 82.9%), with 606, 266 and 168 treated by mbpRFA, LLR and OLR. Most HCCs were solitary (84.8%) and on cirrhosis (89.2%). In months, the follow‐up was 50.2 (95% CI: 45.3, 54.3), 43.3 (95% CI: 40.0, 48.6) and 47.4 (95% CI: 40.8, 58.7) for mbpRFA, LLR and OLR patients. After matching, OLR patients had similar overall survival (OS) (HR = 1.05 [CI 95% = 0.65, 1.69], p = 0.853), transplant‐free survival (TFS) (HR = 0.91 [CI 95% = 0.56, 1.47]; p = 0.690) or recurrence‐free survival (RFS) (HR = 0.99 [CI 95% = 0.69, 1.43]; p = 0.968) compared to mbpRFA patients but with more severe adverse events (RR = 2.58 [CI 95% = 1.16, 5.71]; p = 0.02) and mortality (RR = 4.51 [CI 95% = 1.16, 17.59]; p = 0.03). After matching, LLR patients had better OS (HR = 0.57 [CI 95% = 0.38, 0.88], p = 0.01) but similar TFS (HR = 0.77 [CI 95% = 0.55, 1.1]; p = 0.152) and more severe adverse events (RR = 2.61 [CI 95% = 1.15, 5.96]; p = 0.022) compared to mbpRFA patients. LLR patients had a better RFS (HR = 0.7 [CI 95% = 0.53, 0.91]; p = 0.009) than mbpRFA patients. When distant‐only recurrences were considered in the mbpRFA patients, there was no significant difference in RFS ( p = 0.087). The LLR survival benefit was consistent across pre‐specified subgroups, with no interaction surviving correction for multiple testing.
Conclusions
Minimally invasive modalities (LLR or mbpRFA) should be prioritized when treating early HCC. LLR maximizes oncological outcomes, but mbpRFA maintains optimal TFS with less morbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of HPB Surgery and Liver Transplantation, Beaujon Hospital, AP-HP, Clichy, Paris-Cité University, Paris, France.
- Department of Hepato-Pancreato-Biliary and Liver Transplantation, Hôpitaux Universitaires de Genève, Genève, Switzerland.
- Service de radiologie, CHU Hospices Civils de Lyon, Lyon, France.
- Service de chirurgie Digestive et Transplantation Hépatique, CHU Tours, Université de Tours, Tours, France.
- Service de chirurgie hépatobiliaire et digestive, APHP, CHU Pitié Salpétrière, Paris, France.
- Service de chirurgie hépatobiliaire et digestive, CHU de Rouen, Rouen, France.
ORCID-Profile: Arnaud Hocquelet, Mickaël Lesurtel, Raffaele Brustia, Jean-Charles Nault
Zitieren
APA
Hobeika, C., Cauchy, F., Rode, A., Salamé, E., Scatton, O., Schwarz, L., Papadopoulos, P., Hocquelet, A., Manichon, A. F., Aubé, C., Oberti, F., Corte, A. D., Luciani, A., Gay, S., Lesurtel, M., Lim, C., Nahon, P., Ganne-Carrié, N., Blaise, L., …, & Nault, J. C. (2026). Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis. Liver International. https://doi.org/10.1111/liv.70802
Vancouver
Hobeika C, Cauchy F, Rode A, Salamé E, Scatton O, Schwarz L, et al. Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis. Liver International. 2026. doi:10.1111/liv.70802
BibTeX
@article{Hobeika2026,
author = {Hobeika, Christian and Cauchy, François and Rode, Agnès and Salamé, Ephrem and Scatton, Olivier and Schwarz, Lilian and Papadopoulos, Panteleimon and Hocquelet, Arnaud and Manichon, Anne-Frédérique and Aubé, Christophe and Oberti, Frederic and Corte, Angelo Della and Luciani, Alain and Gay, Suzanne and Lesurtel, Mickaël and Lim, Chetana and Nahon, Pierre and Ganne-Carrié, Nathalie and Blaise, Lorraine and Soubrane, Olivier and Sutter, Olivier and Brustia, Raffaele and Barbier, Louise and Laurent, Alexis and Seror, Olivier and Nault, Jean-Charles},
title = {Laparoscopic or Open Liver Resection Versus Multibipolar Radiofrequency Ablation of HCC Within Milan Criteria on Cirrhosis},
journal = {Liver International},
year = {2026},
doi = {10.1111/liv.70802}
}
EUVIMED